16.48 0.05 (0.3%) | 03-27 15:59 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 20.01 | 1-year : | 20.75 |
Resists | First : | 17.13 | Second : | 17.77 |
Pivot price | 16.49 | |||
Supports | First : | 16.1 | Second : | 13.39 |
MAs | MA(5) : | 16.46 | MA(20) : | 16.71 |
MA(100) : | 17.56 | MA(250) : | 18.55 | |
MACD | MACD : | -0.3 | Signal : | -0.4 |
%K %D | K(14,3) : | 37.5 | D(3) : | 30 |
RSI | RSI(14): 40.7 | |||
52-week | High : | 23.31 | Low : | 16.1 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PSYK ] has closed above bottom band by 48.1%. Bollinger Bands are 62.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 16.52 - 16.6 | 16.6 - 16.67 |
Low: | 16.25 - 16.36 | 16.36 - 16.45 |
Close: | 16.32 - 16.49 | 16.49 - 16.63 |
The fund adviser uses a “passive management” (or indexing) approach to track the performance of the index. The index is a rules-based index that tracks the performance of a portfolio of companies that have business activity in the fields of psychedelic treatment used to address medical conditions in legal pharmacological applications under the applicable country’s laws. The fund will generally invest in all of the component securities of the index in the same approximate proportions as in the index. It is non-diversified.
Fri, 11 Nov 2022
Taking a trip into psychedelic ETFs - ETF Express
Wed, 03 Aug 2022
Horizons Psychedelic ETF Performs 1:4 Share Consolidation | Microdose - Microdose Psychedelic Insights
Thu, 16 Jun 2022
The Four Psychedelics ETFs Capturing Investor Attention - Psychedelic Spotlight
Fri, 29 Apr 2022
World's First Psychedelic ETF to Begin Trading January 27 - Truffle Report
Wed, 27 Apr 2022
North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF? - Psychedelic Alpha
Fri, 25 Feb 2022
Psychedelic ETF Deep Dive: 3 Stocks Outperform Market - Money and Markets
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
AMEX
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 0 (M) |
Shares Float | 0 (M) |
Held by Insiders | 0 (%) |
Held by Institutions | 0 (%) |
Shares Short | 0 (K) |
Shares Short P.Month | 0 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | 0 % |
Return on Assets (ttm) | 0 % |
Return on Equity (ttm) | 0 % |
Qtrly Rev. Growth | 0 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 0 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |